Early Human Prostate Adenocarcinomas Harbor Androgen-Independent Cancer Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Fiñones, Rita R ^a   Yeargin, Jo ^b   Lee, Melissa ^c   Kaur, Aman Preet ^d   Cheng, Clari ^d   Sun, Paulina ^d   Wu, Christopher ^d   Nguyen, Catherine ^d   Wang Rodriguez, Jessica ^c   Meyer, April N ^c   Baird, Stephen M ^c   Donoghue, Daniel J ^b,c   Haas, Martin ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANDROGEN; BIOLOGICAL MARKER; CD133 ANTIGEN; CELL MARKER; HERMES ANTIGEN; PROSTATE SPECIFIC ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 4; STEM CELL FACTOR RECEPTOR; UVOMORULIN; VERY LATE ACTIVATION ANTIGEN 2;

ANDROGEN DEPRIVATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BASAL CELL; CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL ACTIVITY; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; EARLY CANCER; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATECTOMY; PROTEIN EXPRESSION; SPHEROID CELL; STEM CELL; TUMOR XENOGRAFT;

ADENOCARCINOMA; ALDEHYDE DEHYDROGENASE; ANDROGENS; ANIMALS; CASTRATION; CELL COUNT; CELL PROLIFERATION; CELL SHAPE; COLLAGEN; DRUG COMBINATIONS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MALE; MICE; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; PROSTATIC NEOPLASMS; PROTEOGLYCANS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84884586079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074438     Document Type: Article

References (62)

1. Chen Y, Sawyers CL, Scher HI, (2008) Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol 8: 440-448.
2. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, et al. (2004) Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 64: 9209-9216.
3. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, et al. (1994) Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144: 735-746.
4. Feldman BJ, Feldman D, (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34-45.
5. English HF, Santen RJ, Isaacs JT, (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11: 229-242.
6. Kyprianou N, Isaacs JT, (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122: 552-562.
7. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON, (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
8. Masters JR, Kane C, Yamamoto H, Ahmed A, (2008) Prostate cancer stem cell therapy: hype or hope? Prostate Cancer Prostatic Dis 11: 316-319.
9. Gu G, Yuan J, Wills M, Kasper S, (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67: 4807-4815.
10. Qin J, Liu X, Laffin B, Chen X, Choy G, et al. (2012) The PSA (-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10: 556-569.
11. Kelly K, Yin JJ, (2008) Prostate cancer and metastasis initiating stem cells. Cell Res 18: 528-537.
12. Mundy GR, (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593.
13. Signoretti S, Loda M, (2006) Defining cell lineages in the prostate epithelium. Cell Cycle 5: 138-141.
14. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
15. Collins AT, Maitland NJ, (2006) Prostate cancer stem cells. Eur J Cancer 42: 1213-1218.
16. Xin L, Teitell MA, Lawson DA, Kwon A, Mellinghoff IK, et al. (2006) Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci U S A 103: 7789-7794.
17. Xin L, Lawson DA, Witte ON, (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A 102: 6942-6947.
18. Collins AT, Habib FK, Maitland NJ, Neal DE, (2001) Identification and isolation of human prostate epithelial stem cells based on alpha (2) beta (1)-integrin expression. J Cell Sci 114: 3865-3872.
19. Maitland NJ, Collins AT, (2008) Prostate cancer stem cells: a new target for therapy. J Clin Oncol 26: 2862-2870.
20. Miki J, Furusato B, Li H, Gu Y, Takahashi H, et al. (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161.
21. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, et al. (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
22. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, et al. (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219.
23. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, et al. (2007) Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46: 1-14.
24. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, et al. (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8: 494-501.
25. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, et al. (2003) Molecular characterization of human prostate carcinoma cell lines. Prostate 57: 205-225.
26. Dhillon PK, Barry M, Stampfer MJ, Perner S, Fiorentino M, et al. (2009) Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 18: 595-600.
27. Marchitti SA, Brocker C, Stagos D, Vasiliou V, (2008) Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 4: 697-720.
28. Marcato P, Dean CA, Giacomantonio CA, Lee PW, (2011) Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10: 1378-1384.
29. Taubert I, Saffrich R, Zepeda-Moreno A, Hellwig I, Eckstein V, et al. (2011) Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor. Cytotherapy 13: 459-466.
30. Eirew P, Kannan N, Knapp DJ, Vaillant F, Emerman JT, et al. (2012) Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells. Stem Cells 30: 344-348.
31. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
32. Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, et al. (2011) Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29: 32-45.
33. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, et al. (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70: 5163-5173.
34. Lang SH, Stark M, Collins A, Paul AB, Stower MJ, et al. (2001) Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ 12: 631-640.
35. Bastus NC, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC, et al. (2010) Androgen-induced TMPRSS2: ERG fusion in nonmalignant prostate epithelial cells. Cancer Res 70: 9544-9548.
36. Mani RS, Tomlins SA, Callahan K, Ghosh A, Nyati MK, et al. (2009) Induced chromosomal proximity and gene fusions in prostate cancer. Science 326: 1230.
37. Guzman-Ramirez N, Voller M, Wetterwald A, Germann M, Cross NA, et al. (2009) In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 69: 1683-1693.
38. Rajput AB, Miller MA, De Luca A, Boyd N, Leung S, et al. (2007) Frequency of the TMPRSS2: ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. J Clin Pathol 60: 1238-1243.
39. Norris PS, Jepsen K, Haas M, (1998) High-titer MSCV-based retrovirus generated in the pCL acute virus packaging system confers sustained gene expression in vivo. J Virol Methods 75: 161-167.
40. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, et al. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61: 8135-8142.
41. Li H, Zhou J, Miki J, Furusato B, Gu Y, et al. (2008) Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells. Exp Cell Res 314: 92-102.
42. Eaton CL, Colombel M, van der Pluijm G, Cecchini M, Wetterwald A, et al. (2010) Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. Prostate 70: 875-882.
43. Wei C, Guomin W, Yujun L, Ruizhe Q, (2007) Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther 6: 763-768.
44. Cunha GR, Hayashi N, Wong YC, (1991) Regulation of differentiation and growth of normal adult and neoplastic epithelia by inductive mesenchyme. Cancer Surv 11: 73-90.
45. Wong YC, Cunha GR, Hayashi N, (1992) Effects of mesenchyme of the embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study. Acta Anat (Basel) 143: 139-150.
46. Ruiz M, Troncoso P, Bruns C, Bar-Eli M, (2001) Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Clin Cancer Res 7: 4086-4095.
47. Wang XD, Leow CC, Zha J, Tang Z, Modrusan Z, et al. (2006) Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol 290: 66-80.
48. Hayashi N, Cunha GR, Parker M, (1993) Permissive and instructive induction of adult rodent prostatic epithelium by heterotypic urogenital sinus mesenchyme. Epithelial Cell Biol 2: 66-78.
49. Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, et al. (2009) Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation 77: 95-102.
50. Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, et al. (2012) Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer 12: 767-775.
51. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
52. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
53. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
54. Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, et al. (2013) New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. J Mol Cell Biol 5: 14-26.
55. Bhatt RI, Brown MD, Hart CA, Gilmore P, Ramani VA, et al. (2003) Novel method for the isolation and characterisation of the putative prostatic stem cell. Cytometry A 54: 89-99.
56. Pascal LE, Oudes AJ, Petersen TW, Goo YA, Walashek LS, et al. (2007) Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol 7: 6.
57. Brown MD, Gilmore PE, Hart CA, Samuel JD, Ramani VA, et al. (2007) Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67: 1384-1396.
58. Mathew G, Timm EA Jr, Sotomayor P, Godoy A, Montecinos VP, et al. (2009) ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate. Cell Cycle 8: 1053-1061.
59. Buhler P, Wolf P, Katzenwadel A, Schultze-Seemann W, Wetterauer U, et al. (2010) Primary prostate cancer cultures are models for androgen-independent transit amplifying cells. Oncol Rep 23: 465-470.
60. Bisson I, Prowse DM, (2009) WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 19: 683-697.
61. Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, et al. (2008) Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem 283: 27957-27972.
62. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI, (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2: 162.